| A hot L1 retrotransposon evades somatic repression and initiates human colorectal cancer EC Scott, EJ Gardner, A Masood, NT Chuang, PM Vertino, SE Devine Genome research 26 (6), 745-755, 2016 | 286 | 2016 |
| Tumor mutation burden as a biomarker in resected non–small-cell lung cancer S Devarakonda, F Rotolo, MS Tsao, I Lanc, E Brambilla, A Masood, ... Journal of Clinical Oncology 36 (30), 2995, 2018 | 235 | 2018 |
| Recurrent WNT pathway alterations are frequent in relapsed small cell lung cancer AH Wagner, S Devarakonda, ZL Skidmore, K Krysiak, A Ramu, L Trani, ... Nature communications 9 (1), 3787, 2018 | 126 | 2018 |
| Comparative proteogenomic analysis of right-sided colon cancer, left-sided colon cancer and rectal cancer reveals distinct mutational profiles R Imperial, Z Ahmed, OM Toor, C Erdoğan, A Khaliq, P Case, J Case, ... Molecular cancer 17, 1-7, 2018 | 94 | 2018 |
| Current and emerging therapies for advanced biliary tract cancers AE Kam, A Masood, RT Shroff The lancet Gastroenterology & hepatology 6 (11), 956-969, 2021 | 88 | 2021 |
| Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in non-small cell lung cancer harboring uncommon EGFR mutations: Focus on afatinib A Masood, RK Kancha, J Subramanian Seminars in oncology 46 (3), 271-283, 2019 | 88 | 2019 |
| Adjuvant chemotherapy for patients with T2N0M0 NSCLC D Morgensztern, L Du, SN Waqar, A Patel, P Samson, S Devarakonda, ... Journal of Thoracic Oncology 11 (10), 1729-1735, 2016 | 87 | 2016 |
| Primary non-Hodgkin lymphoma of liver A Masood, S Kairouz, KH Hudhud, AZ Hegazi, A Banu, NC Gupta Current Oncology 16 (4), 74-77, 2009 | 82 | 2009 |
| Progress in nanotechnology based approaches to enhance the potential of chemopreventive agents I Muqbil, A Masood, FH Sarkar, RM Mohammad, AS Azmi Cancers 3 (1), 428-445, 2011 | 77 | 2011 |
| Emergence of ERBB2 Mutation as a Biomarker and an Actionable Target in Solid Cancers J Subramanian, A Katta, A Masood, DR Vudem, RK Kancha The oncologist 24 (12), e1303-e1314, 2019 | 74 | 2019 |
| Comprehensive pancancer genomic analysis reveals (RTK)-RAS-RAF-MEK as a key dysregulated pathway in cancer: Its clinical implications R Imperial, OM Toor, A Hussain, J Subramanian, A Masood Seminars in cancer biology 54, 14-28, 2019 | 68 | 2019 |
| Refining colorectal cancer classification and clinical stratification through a single-cell atlas AM Khaliq, C Erdogan, Z Kurt, SS Turgut, MW Grunvald, T Rand, S Khare, ... Genome biology 23 (1), 113, 2022 | 65 | 2022 |
| A pan-cancer organoid platform for precision medicine BM Larsen, M Kannan, LF Langer, BD Leibowitz, A Bentaieb, A Cancino, ... Cell reports 36 (4), 2021 | 63 | 2021 |
| Evaluating feasibility and acceptability of a group WHO trans-diagnostic intervention for women with common mental disorders in rural Pakistan: a cluster randomised controlled … MN Khan, SU Hamdani, A Chiumento, K Dawson, RA Bryant, M Sijbrandij, ... Epidemiology and Psychiatric Sciences 28 (1), 77-87, 2019 | 61 | 2019 |
| Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label … S Qin, M Chen, AL Cheng, AO Kaseb, M Kudo, HC Lee, AC Yopp, J Zhou, ... The Lancet 402 (10415), 1835-1847, 2023 | 56 | 2023 |
| Estimating 1-and 5-year relative survival trends in colorectal cancer (CRC) in the United States: 2004 to 2014. H Crooke, M Kobayashi, B Mitchell, E Nwokeji, M Laurie, S Kamble, ... Journal of Clinical Oncology 36 (4_suppl), 587-587, 2018 | 56 | 2018 |
| The role of systemic therapy in the management of stage I large cell neuroendocrine carcinoma of the lung L Kujtan, V Muthukumar, KF Kennedy, JR Davis, A Masood, ... Journal of Thoracic Oncology 13 (5), 707-714, 2018 | 55 | 2018 |
| Small molecule inhibitors of bcl-2 family proteins for pancreatic cancer therapy A Masood, AS Azmi, RM Mohammad Cancers 3 (2), 1527-1549, 2011 | 53 | 2011 |
| Genomic profiling of lung adenocarcinoma in never-smokers S Devarakonda, Y Li, F Martins Rodrigues, S Sankararaman, H Kadara, ... Journal of Clinical Oncology 39 (33), 3747-3758, 2021 | 51 | 2021 |
| Current status of circulating tumor DNA liquid biopsy in pancreatic cancer MW Grunvald, RA Jacobson, TM Kuzel, SG Pappas, A Masood International Journal of Molecular Sciences 21 (20), 7651, 2020 | 44 | 2020 |
